TY  - RPRT
TI  - Re-profiling of natural inhibitor via combinatorial drug screening: Brefeldin A variant design as an effective antagonist leading to EPAC2 structure modification and antibody design for identification
AU  - Uttarkar, A.
AU  - Niranjan, V.
PY  - 2021
DO  - 10.1101/2021.03.31.437986
UR  - https://www.biorxiv.org/content/10.1101/2021.03.31.437986v1
ID  - 10.1101/2021.03.31.437986
ER  -